UC-CARE NaviGo Workstation
System, Image Processing, Radiological. 510(k) K160934, from UC-CARE , Ltd. (Yokneam, IL). Product code LLZ, class 2.
As of Nov 20, 2026, K160934 is an FDA 510(k) held by UC-CARE , Ltd., substantially equivalent on Feb 6, 2017 after 308 days, with no recalls tied to it in FDA's recall database.
- Review time: 308 days
- Recalls: 0
- Cited as a predicate by: 1 device
The UC-CARE NaviGo Workstation is an adjunctive tool for ultrasound guided procedures and is intended to be used by physicians in the clinic or hospital for 2-D and 3-D visualization of ultrasound images of the prostate gland. The NaviGo™ Workstation offers the ability to fuse DICOM originated information (e.g.
- Uc-Care Navigo SytemK100784 · UC-CARE , Ltd. · Nov 1, 2011
- 3D Prostate Suite 3Dtrus Prostate Mapping, MRI/3Dtrus Fusion Option, Second Look 3Dtrus Fusion OptionK131448 · Koelis · Jul 26, 2013
- Navigo Workstation Version 2.0K173054 · UC-CARE , Ltd. · Jan 16, 2018
- 3D Anatomical ModelK262132 · The Jacobs Institute · Nov 5, 2026
- LiLi DICOM Viewer (LiLi )K260454 · Elevate Imaging, Inc. · Nov 4, 2026
- Vitrea Advanced Visualization, Version 7.16K263648 · Canon Medical Informatics, Inc. · Oct 29, 2026
- MIM – KineticIDK261763 · Mim Software, Inc. · Oct 26, 2026
- PV-iCurve ProK261531 · Perception Vision Medical Technology Co., Ltd. · Oct 21, 2026
- Eden PACSK261788 · Higia., Inc. d/b/a Eden · Oct 21, 2026
- Syngo Carbon Space (VA4)K263048 · Siemens Healthineers AG · Sep 29, 2026
- Syneris PACS v.1.0.1.0K261874 · Syneris · Sep 23, 2026
- Document
- 510(k) summary (PDF) ↗
- Type
- Traditional
- Received
- Apr 4, 2016
- Review panel
- Radiology
- Regulation
- 21 CFR 892.2050
One page per 510(k), De Novo and original PMA. Recalls are those FDA's recall database ties to this number; recalls of related devices that cite another number are not shown. Refreshed weekly. Predicates are read by Arca from the text of FDA's 510(k) summary PDFs, most of them scans: a device number counts when the summary names it as a predicate or as the device it is substantially equivalent to. About 97% of those read were right on a sample we checked by hand; summaries from before 2000 often name predicates without a number, so older devices show fewer. Pivotal studies are read by a model from FDA's De Novo decision summaries and PMA SSEDs; a count or result is shown only when its numbers appear in FDA's text. openFDA device 510(k), PMA and recall files